POTENTIAL BIOLOGIC AGENTS FOR TREATING RHEUMATOID ARTHRITIS
- 1 May 2001
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 27 (2) , 445-491
- https://doi.org/10.1016/s0889-857x(05)70212-x
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritisEuropean Journal of Immunology, 1999
- C-MYC antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytesArthritis & Rheumatism, 1999
- Limited heterogeneity of rearranged T cell receptor Vα and Vβ transcripts in synovial fluid T cells in early stages of rheumatoid arthritisArthritis & Rheumatism, 1996
- Changes in cartilage composition and physical properties due to stromelysin degradationArthritis & Rheumatism, 1995
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibodyArthritis & Rheumatism, 1991
- Biologic effects of an interleukin‐1 receptor antagonist protein on interleukin‐1–stimulated cartilage erosion and chondrocyte responsivenessArthritis & Rheumatism, 1991
- Double‐blind trial of recombinant γ‐interferon versus placebo in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1989
- Treatment with gamma‐interferon triggers the onset of collagen arthritis in miceArthritis & Rheumatism, 1988
- Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritidesArthritis & Rheumatism, 1988